Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...
Sep 11, 2018
0
13
A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing ...
Canadian health and wellness company PreveCeutical Medical Inc. (PMI) has signed a research and option agreement with UniQuest, The University of Queensland's main commercialisation company, to develop stabilised natural ...
Apr 21, 2017
0
1
Signal molecules called chemokines often work in tandem to recruit specific sets of immune cells to sites of tissue damage. A systematic analysis of their interactions by researchers from Ludwig-Maximilians-Universitaet (LMU) ...
Apr 6, 2017
0
0
A new approach to treating grass allergies offers potential as a shorter and more effective alternative to traditional allergy shots, according to a recent study led by Queen's researcher Dr. Anne Ellis (Medicine, Biomedical ...
Feb 23, 2017
0
0
Health workers may soon have a new weapon in the fight against abscesses—difficult-to-treat bacterial infections that lead to millions of emergency-room visits every year.
Sep 28, 2016
0
1
Scientists at The Scripps Research Institute (TSRI) have created a synthetic molecule that mimics "good" cholesterol and have shown it can reduce plaque buildup in the arteries of animal models. The molecule, taken orally, ...
Oct 10, 2014
0
0
Researchers at Mayo Clinic have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer chemotherapy drugs and other neurological medications. ...
Jun 4, 2014
0
0
Northwestern Medicine scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease.
Nov 11, 2013
0
1
(Edmonton) Researchers at the University of Alberta have developed a synthetic peptide that could be the first in a new class of drugs to treat heart disease, high blood pressure and diabetes.
Sep 17, 2013
0
0
